Updated Jul 16, 2026 · Last SEC filing 2026-07-06
Jazz Pharmaceuticals plc (JAZZ) has filed 16 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-06. 2 Form 8-K material event filings were reported by JAZZ in the last 90 days. 9 Form 144 notices of proposed sale were filed for JAZZ stock. InsiderAlpha tracks every JAZZ SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
|---|---|
| SEC CIK | 0001232524 |
| Form 4 filings (90d) | 16 |
|---|---|
| Form 8-K filings (90d) | 2 |
| Form 144 notices (90d) | 9 |
| Latest Form 4 filing | 2026-07-06 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| COZADD BRUCE C | Director | S — Open-market sale | 6.0K | $240.47 | $1.44M | SEC | |
| Iannone Robert | EVP, Global Head of R&D & CMO | F — Tax withholding / forfeiture | 3.8K | $237.72 | $895K | SEC | |
| Patil Neena M | EVP & Chief Legal Officer | F — Tax withholding / forfeiture | 2.7K | $237.72 | $637K | SEC | |
| Pearce Samantha | EVP, Chief Commercial Officer | F — Tax withholding / forfeiture | 2.5K | $237.72 | $601K | SEC | |
| GALA RENEE D | President & CEO | F — Tax withholding / forfeiture | 4.8K | $237.72 | $1.15M | SEC | |
| Johnson Philip L | EVP & Chief Financial Officer | F — Tax withholding / forfeiture | 3.3K | $237.72 | $795K | SEC | |
| Smith Mark Douglas | Director | S — Open-market sale | 1.2K | $230.55 | $267K | SEC | |
| Patil Neena M | EVP & Chief Legal Officer | S — Open-market sale | 1.2K | $231.83 | $278K | SEC | |
| GALA RENEE D | President & CEO | G — Bona-fide gift | 600 | $0.00 | — | SEC | |
| COZADD BRUCE C | Director | S — Open-market sale | 6.0K | $235.12 | $1.41M | SEC | |
| Mulligan Seamus | Director | M — Option exercise | 3.4K | $138.08 | $472K | SEC | |
| Pearce Samantha | EVP, Chief Commercial Officer | M — Option exercise | 6.9K | $109.45 | $756K | SEC | |
| Pearce Samantha | EVP, Chief Commercial Officer | S — Open-market sale | 6.9K | $235.41 | $1.63M | SEC | |
| Patil Neena M | EVP & Chief Legal Officer | S — Open-market sale | 1.2K | $236.97 | $282K | SEC | |
| Winningham Rick E | Director | S — Open-market sale | 2.7K | $241.57 | $662K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Jazz Pharmaceuticals plc (JAZZ). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Pearce Samantha | 4 | $2.98M |
| Patil Neena M | 3 | $1.20M |
| COZADD BRUCE C | 3 | $4.07M |
| Winningham Rick E | 3 | $1.13M |
| Mulligan Seamus | 2 | $472K |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in JAZZ insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live JAZZ dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.